High resolution crystal structures of the trans-enamine intermediates formed by sulbactam and clavulanic acid and E166A SHV-1 {beta}-lactamase (Q46628237)

From Wikidata

Jump to navigation Jump to search

scientific article published on 29 July 2005

Language	Label	Description	Also known as
English	High resolution crystal structures of the trans-enamine intermediates formed by sulbactam and clavulanic acid and E166A SHV-1 {beta}-lactamase	scientific article published on 29 July 2005

Statements

scholarly article

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16055923

High resolution crystal structures of the trans-enamine intermediates formed by sulbactam and clavulanic acid and E166A SHV-1 {beta}-lactamase (English)

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16055923

crystal structure

1 reference

based on heuristic

inferred from title

Robert A Bonomo

6

object named as

Robert A Bonomo

1 reference

Europe PubMed Central

23 December 2017

3

object named as

Monica A Totir

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16055923

author name string

Pius S Padayatti

1

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16055923

Marion S Helfand

2

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16055923

Marianne P Carey

4

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16055923

Paul R Carey

5

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16055923

Focco van den Akker

7

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16055923

language of work or name

0 references

publication date

29 July 2005

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16055923

Journal of Biological Chemistry

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16055923

280

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16055923

41

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16055923

34900-34907

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16055923

Beta-lactamases: a survey of protein diversity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505333200

21 January 2018

Clinical role of beta-lactam/beta-lactamase inhibitor combinations

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505333200

21 January 2018

Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505333200

21 January 2018

Chemical studies on the inactivation of Escherichia coli RTEM β-lactamase by clavulanic acid

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505333200

21 January 2018

Kinetic studies on the inactivation of Escherichia coli RTEM β-lactamase by clavulanic acid

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505333200

21 January 2018

β-Lactamase inactivation by mechanism-based reagents

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505333200

21 January 2018

Inhibition of TEM-2 beta-lactamase from Escherichia coli by clavulanic acid: observation of intermediates by electrospray ionization mass spectrometry.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505333200

21 January 2018

Inactivation of CMY-2 beta-lactamase by tazobactam: initial mass spectroscopic characterization

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505333200

21 January 2018

Enzyme-induced strain/distortion in the ground-state ES complex in beta-lactamase catalysis revealed by FTIR.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505333200

21 January 2018

Inhibition of the SHV-1 beta-lactamase by sulfones: crystallographic observation of two reaction intermediates with tazobactam

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505333200

21 January 2018

Inhibitor-resistant class A beta-lactamases: consequences of the Ser130-to-Gly mutation seen in Apo and tazobactam structures of the SHV-1 variant

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505333200

21 January 2018

Molecular structure of the acyl-enzyme intermediate in beta-lactam hydrolysis at 1.7 A resolution

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505333200

21 January 2018

Crystal structure of the E166A mutant of extended-spectrum beta-lactamase Toho-1 at 1.8 A resolution

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505333200

21 January 2018

Following the Reactions of Mechanism-Based Inhibitors with β-Lactamase by Raman Crystallography

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505333200

21 January 2018

Tazobactam forms a stoichiometric trans-enamine intermediate in the E166A variant of SHV-1 beta-lactamase: 1.63 A crystal structure

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505333200

21 January 2018

The finer things in X-ray diffraction data collection

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505333200

21 January 2018

Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505333200

21 January 2018

Improved methods for building protein models in electron density maps and the location of errors in these models

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505333200

21 January 2018

Ultrahigh resolution structure of a class A beta-lactamase: on the mechanism and specificity of the extended-spectrum SHV-2 enzyme

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505333200

21 January 2018

PROCHECK: a program to check the stereochemical quality of protein structures

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505333200

21 January 2018

Structure of the SHV-1 beta-lactamase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505333200

21 January 2018

Clavulanic acid inactivation of SHV-1 and the inhibitor-resistant S130G SHV-1 beta-lactamase. Insights into the mechanism of inhibition

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505333200

21 January 2018

beta-Lactamase inhibition and in vitro activity of sulbactam and sulbactam/cefoperazone

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505333200

21 January 2018

Resonance Raman spectroscopic studies of 2,4-dinitrophenyl hapten-antibody interactions

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505333200

21 January 2018

beta-Lactamase mutations far from the active site influence inhibitor binding.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505333200

21 January 2018

Inhibitor resistant class A beta-lactamases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505333200

21 January 2018

Beta-lactamase inhibitors: evolving compounds for evolving resistance targets

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505333200

21 January 2018

Identifiers

10.1074/JBC.M505333200

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16055923

release_swi45ciqubfntd2buqnpibaexu

1 reference

https://api.fatcat.wiki/v0/release/swi45ciqubfntd2buqnpibaexu

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16055923

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46628237&oldid=2123063021"